1.
Visentin A, Trentin L. Response to ‚ÄúCardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients‚ÄĚ. haematol [Internet]. 2021Nov.18 [cited 2022Jan.16];. Available from: https://haematologica.org/article/view/haematol.2021.280199